Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
5
แน160แน422028
58%
chance
1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will ANY of {metformin, canagliflozin, acarbose, rapamycin} be made OTC to purchase in US by Jan2028?
48% chance
Will Jose Luis ricon finally start regularly taking rapamycin by 2030?
45% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
16% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
88% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
51% chance
Any myostatin inhibitor FDA approved by 2027
38% chance
Will jurgen schmidhuber end up taking rapamycin by EOY 2028
41% chance